Pre-order Enquiry
Request Free Sample
Global Systemic Idiopathic Juvenile Arthritis Treatment Market Insights, Forecast to 2028
SKU ID : QYR-20292100 | Publishing Date : 22-Feb-2022 | No. of pages : 90
Detailed TOC of Global Systemic Idiopathic Juvenile Arthritis Treatment Market Insights, Forecast to 2028
1 Report Business Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Adalimumab Biosimilar
1.2.3 Canakinumab
1.2.4 Golimumab
1.2.5 Tocilizumab Biosimilar
1.2.6 Others
1.3 Market by Application
1.3.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Market Perspective (2017-2028)
2.2 Systemic Idiopathic Juvenile Arthritis Treatment Growth Trends by Region
2.2.1 Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Systemic Idiopathic Juvenile Arthritis Treatment Historic Market Size by Region (2017-2022)
2.2.3 Systemic Idiopathic Juvenile Arthritis Treatment Forecasted Market Size by Region (2023-2028)
2.3 Systemic Idiopathic Juvenile Arthritis Treatment Market Dynamics
2.3.1 Systemic Idiopathic Juvenile Arthritis Treatment Industry Trends
2.3.2 Systemic Idiopathic Juvenile Arthritis Treatment Market Drivers
2.3.3 Systemic Idiopathic Juvenile Arthritis Treatment Market Challenges
2.3.4 Systemic Idiopathic Juvenile Arthritis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Systemic Idiopathic Juvenile Arthritis Treatment Players by Revenue
3.1.1 Global Top Systemic Idiopathic Juvenile Arthritis Treatment Players by Revenue (2017-2022)
3.1.2 Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Systemic Idiopathic Juvenile Arthritis Treatment Revenue
3.4 Global Systemic Idiopathic Juvenile Arthritis Treatment Market Concentration Ratio
3.4.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Systemic Idiopathic Juvenile Arthritis Treatment Revenue in 2021
3.5 Systemic Idiopathic Juvenile Arthritis Treatment Key Players Head office and Area Served
3.6 Key Players Systemic Idiopathic Juvenile Arthritis Treatment Product Solution and Service
3.7 Date of Enter into Systemic Idiopathic Juvenile Arthritis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Systemic Idiopathic Juvenile Arthritis Treatment Breakdown Data by Type
4.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Historic Market Size by Type (2017-2022)
4.2 Global Systemic Idiopathic Juvenile Arthritis Treatment Forecasted Market Size by Type (2023-2028)
5 Systemic Idiopathic Juvenile Arthritis Treatment Breakdown Data by Application
5.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Historic Market Size by Application (2017-2022)
5.2 Global Systemic Idiopathic Juvenile Arthritis Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size (2017-2028)
6.2 North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type
6.2.1 North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2017-2022)
6.2.2 North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2023-2028)
6.2.3 North America Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Type (2017-2028)
6.3 North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application
6.3.1 North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2017-2022)
6.3.2 North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2023-2028)
6.3.3 North America Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Application (2017-2028)
6.4 North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country
6.4.1 North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2017-2022)
6.4.2 North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size (2017-2028)
7.2 Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type
7.2.1 Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2017-2022)
7.2.2 Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2023-2028)
7.2.3 Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Type (2017-2028)
7.3 Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application
7.3.1 Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2017-2022)
7.3.2 Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2023-2028)
7.3.3 Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Application (2017-2028)
7.4 Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country
7.4.1 Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2017-2022)
7.4.2 Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size (2017-2028)
8.2 Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type
8.2.1 Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application
8.3.1 Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Region
8.4.1 Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size (2017-2028)
9.2 Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type
9.2.1 Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Type (2017-2028)
9.3 Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application
9.3.1 Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Application (2017-2028)
9.4 Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country
9.4.1 Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size (2017-2028)
10.2 Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type
10.2.1 Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application
10.3.1 Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country
10.4.1 Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Alteogen Inc.
11.1.1 Alteogen Inc. Company Details
11.1.2 Alteogen Inc. Business Overview
11.1.3 Alteogen Inc. Systemic Idiopathic Juvenile Arthritis Treatment Introduction
11.1.4 Alteogen Inc. Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2017-2022)
11.1.5 Alteogen Inc. Recent Developments
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Company Details
11.2.2 Bristol-Myers Squibb Company Business Overview
11.2.3 Bristol-Myers Squibb Company Systemic Idiopathic Juvenile Arthritis Treatment Introduction
11.2.4 Bristol-Myers Squibb Company Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2017-2022)
11.2.5 Bristol-Myers Squibb Company Recent Developments
11.3 Epirus Biopharmaceuticals, Inc.
11.3.1 Epirus Biopharmaceuticals, Inc. Company Details
11.3.2 Epirus Biopharmaceuticals, Inc. Business Overview
11.3.3 Epirus Biopharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Introduction
11.3.4 Epirus Biopharmaceuticals, Inc. Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2017-2022)
11.3.5 Epirus Biopharmaceuticals, Inc. Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Systemic Idiopathic Juvenile Arthritis Treatment Introduction
11.4.4 Johnson & Johnson Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2017-2022)
11.4.5 Johnson & Johnson Recent Developments
11.5 Momenta Pharmaceuticals, Inc.
11.5.1 Momenta Pharmaceuticals, Inc. Company Details
11.5.2 Momenta Pharmaceuticals, Inc. Business Overview
11.5.3 Momenta Pharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Introduction
11.5.4 Momenta Pharmaceuticals, Inc. Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2017-2022)
11.5.5 Momenta Pharmaceuticals, Inc. Recent Developments
11.6 Mycenax Biotech Inc.
11.6.1 Mycenax Biotech Inc. Company Details
11.6.2 Mycenax Biotech Inc. Business Overview
11.6.3 Mycenax Biotech Inc. Systemic Idiopathic Juvenile Arthritis Treatment Introduction
11.6.4 Mycenax Biotech Inc. Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2017-2022)
11.6.5 Mycenax Biotech Inc. Recent Developments
11.7 Novartis AG
11.7.1 Novartis AG Company Details
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG Systemic Idiopathic Juvenile Arthritis Treatment Introduction
11.7.4 Novartis AG Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2017-2022)
11.7.5 Novartis AG Recent Developments
11.8 Oncobiologics, Inc.
11.8.1 Oncobiologics, Inc. Company Details
11.8.2 Oncobiologics, Inc. Business Overview
11.8.3 Oncobiologics, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Introduction
11.8.4 Oncobiologics, Inc. Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2017-2022)
11.8.5 Oncobiologics, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Figures, Tables and Charts Available in Global Systemic Idiopathic Juvenile Arthritis Treatment Market Insights, Forecast to 2028
List of TablesTable 1. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Adalimumab Biosimilar
Table 3. Key Players of Canakinumab
Table 4. Key Players of Golimumab
Table 5. Key Players of Tocilizumab Biosimilar
Table 6. Key Players of Others
Table 7. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Region (2017-2022)
Table 11. Global Systemic Idiopathic Juvenile Arthritis Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Region (2023-2028)
Table 13. Systemic Idiopathic Juvenile Arthritis Treatment Market Trends
Table 14. Systemic Idiopathic Juvenile Arthritis Treatment Market Drivers
Table 15. Systemic Idiopathic Juvenile Arthritis Treatment Market Challenges
Table 16. Systemic Idiopathic Juvenile Arthritis Treatment Market Restraints
Table 17. Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue Share by Players (2017-2022)
Table 19. Global Top Systemic Idiopathic Juvenile Arthritis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Idiopathic Juvenile Arthritis Treatment as of 2021)
Table 20. Ranking of Global Top Systemic Idiopathic Juvenile Arthritis Treatment Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Systemic Idiopathic Juvenile Arthritis Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Systemic Idiopathic Juvenile Arthritis Treatment Product Solution and Service
Table 24. Date of Enter into Systemic Idiopathic Juvenile Arthritis Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue Market Share by Type (2017-2022)
Table 28. Global Systemic Idiopathic Juvenile Arthritis Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue Market Share by Type (2023-2028)
Table 30. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue Share by Application (2017-2022)
Table 32. Global Systemic Idiopathic Juvenile Arthritis Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue Share by Application (2023-2028)
Table 34. North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 64. Alteogen Inc. Company Details
Table 65. Alteogen Inc. Business Overview
Table 66. Alteogen Inc. Systemic Idiopathic Juvenile Arthritis Treatment Product
Table 67. Alteogen Inc. Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2017-2022) & (US$ Million)
Table 68. Alteogen Inc. Recent Developments
Table 69. Bristol-Myers Squibb Company Company Details
Table 70. Bristol-Myers Squibb Company Business Overview
Table 71. Bristol-Myers Squibb Company Systemic Idiopathic Juvenile Arthritis Treatment Product
Table 72. Bristol-Myers Squibb Company Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2017-2022) & (US$ Million)
Table 73. Bristol-Myers Squibb Company Recent Developments
Table 74. Epirus Biopharmaceuticals, Inc. Company Details
Table 75. Epirus Biopharmaceuticals, Inc. Business Overview
Table 76. Epirus Biopharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Product
Table 77. Epirus Biopharmaceuticals, Inc. Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2017-2022) & (US$ Million)
Table 78. Epirus Biopharmaceuticals, Inc. Recent Developments
Table 79. Johnson & Johnson Company Details
Table 80. Johnson & Johnson Business Overview
Table 81. Johnson & Johnson Systemic Idiopathic Juvenile Arthritis Treatment Product
Table 82. Johnson & Johnson Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2017-2022) & (US$ Million)
Table 83. Johnson & Johnson Recent Developments
Table 84. Momenta Pharmaceuticals, Inc. Company Details
Table 85. Momenta Pharmaceuticals, Inc. Business Overview
Table 86. Momenta Pharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Product
Table 87. Momenta Pharmaceuticals, Inc. Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2017-2022) & (US$ Million)
Table 88. Momenta Pharmaceuticals, Inc. Recent Developments
Table 89. Mycenax Biotech Inc. Company Details
Table 90. Mycenax Biotech Inc. Business Overview
Table 91. Mycenax Biotech Inc. Systemic Idiopathic Juvenile Arthritis Treatment Product
Table 92. Mycenax Biotech Inc. Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2017-2022) & (US$ Million)
Table 93. Mycenax Biotech Inc. Recent Developments
Table 94. Novartis AG Company Details
Table 95. Novartis AG Business Overview
Table 96. Novartis AG Systemic Idiopathic Juvenile Arthritis Treatment Product
Table 97. Novartis AG Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2017-2022) & (US$ Million)
Table 98. Novartis AG Recent Developments
Table 99. Oncobiologics, Inc. Company Details
Table 100. Oncobiologics, Inc. Business Overview
Table 101. Oncobiologics, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Product
Table 102. Oncobiologics, Inc. Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2017-2022) & (US$ Million)
Table 103. Oncobiologics, Inc. Recent Developments
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Type: 2021 VS 2028
Figure 2. Adalimumab Biosimilar Features
Figure 3. Canakinumab Features
Figure 4. Golimumab Features
Figure 5. Tocilizumab Biosimilar Features
Figure 6. Others Features
Figure 7. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Application: 2021 VS 2028
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Others Case Studies
Figure 11. Systemic Idiopathic Juvenile Arthritis Treatment Report Years Considered
Figure 12. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Region: 2021 VS 2028
Figure 15. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Players in 2021
Figure 16. Global Top Systemic Idiopathic Juvenile Arthritis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Idiopathic Juvenile Arthritis Treatment as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Systemic Idiopathic Juvenile Arthritis Treatment Revenue in 2021
Figure 18. North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size Market Share by Type (2017-2028)
Figure 20. North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size Market Share by Application (2017-2028)
Figure 21. North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size Share by Country (2017-2028)
Figure 22. United States Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size Market Share by Type (2017-2028)
Figure 26. Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size Market Share by Application (2017-2028)
Figure 27. Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size Share by Country (2017-2028)
Figure 28. Germany Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size Share by Region (2017-2028)
Figure 38. China Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size Share by Country (2017-2028)
Figure 48. Mexico Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size Share by Country (2017-2028)
Figure 54. Turkey Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Alteogen Inc. Revenue Growth Rate in Systemic Idiopathic Juvenile Arthritis Treatment Business (2017-2022)
Figure 58. Bristol-Myers Squibb Company Revenue Growth Rate in Systemic Idiopathic Juvenile Arthritis Treatment Business (2017-2022)
Figure 59. Epirus Biopharmaceuticals, Inc. Revenue Growth Rate in Systemic Idiopathic Juvenile Arthritis Treatment Business (2017-2022)
Figure 60. Johnson & Johnson Revenue Growth Rate in Systemic Idiopathic Juvenile Arthritis Treatment Business (2017-2022)
Figure 61. Momenta Pharmaceuticals, Inc. Revenue Growth Rate in Systemic Idiopathic Juvenile Arthritis Treatment Business (2017-2022)
Figure 62. Mycenax Biotech Inc. Revenue Growth Rate in Systemic Idiopathic Juvenile Arthritis Treatment Business (2017-2022)
Figure 63. Novartis AG Revenue Growth Rate in Systemic Idiopathic Juvenile Arthritis Treatment Business (2017-2022)
Figure 64. Oncobiologics, Inc. Revenue Growth Rate in Systemic Idiopathic Juvenile Arthritis Treatment Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Keyplayers in Global Systemic Idiopathic Juvenile Arthritis Treatment Market Insights, Forecast to 2028
Alteogen Inc.Bristol-Myers Squibb Company
Epirus Biopharmaceuticals, Inc.
Johnson & Johnson
Momenta Pharmaceuticals, Inc.
Mycenax Biotech Inc.
Novartis AG
Oncobiologics, Inc.
Request Sample
Request Discount
